Nebulized tiny particles for allergic rhinitis with asthma
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests if breathing in tiny particles (small extracellular vesicles) through a nebulizer can help treat allergic rhinitis with asthma when standard allergy meds haven't worked well. It's for adults who have moderate to severe symptoms and are not adequately controlled.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have moderate to severe allergic rhinitis (symptoms affecting sleep, work, or daily life) and asthma.
- Standard allergy medications have not worked well for you in the past year.
- You cannot or choose not to have allergy shots or immunotherapy.
- You are not currently using meds like beta-blockers or ACE inhibitors.
- You are not pregnant, planning pregnancy, or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
This study looks at blood and other measures (biomarkers) to understand how well mepolizumab helps people with nasal polyps, with or without asthma. It aims to find response clues that could help personalize treatment in the future.
This trial tests whether a seawater nasal spray can relieve nasal congestion, runny nose, and other sinus symptoms in people with colds, allergies, or after nose surgery. You will use the spray as directed and answer online questionnaires for up to 3 months.
This study tests a new type of treatment using a mist (nebulized) made from stem cell byproducts to see if it can safely help people with a rare autoimmune lung disease. It is for patients with anti-MDA5 positive dermatomyositis who have a fast-progressing lung condition.
This trial tests a new nasal drop treatment made from stem cells for people with Alzheimer's, Parkinson's, multiple system atrophy, Lewy body dementia, frontotemporal dementia, or ALS. The drops may help slow disease progression by delivering tiny healing particles directly to the brain through the nose.
This early-stage trial tests a new nasal spray combining stem cell-derived material, an antibiotic, and an enzyme to treat chronic sinus infections caused by a specific bacteria. The goal is to reduce inflammation and infection in people who have had symptoms for over 3 months.
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.